Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

New hope for heart failure patients

Dec. 3, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

XOMA receives U.S. patents covering BPI-related products

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...